On Thursday, September 4, 2025, Codexis (NASDAQ:CDXS) presented at the Cantor Global Healthcare Conference, outlining its strategic focus on enzymatic synthesis for siRNA therapeutics. The company ...

REDWOOD CITY, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, ...

Advancements in peptide and oligonucleotide synthesis via precision chemistry are transforming therapeutic development by enabling improved scalability and purity.

REDWOOD CITY, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc., a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, presented data at ...